Tag Archives: RELX

Top 10 Medical Stocks To Own Right Now

Primo Water (NASDAQ:PRMW) had its price objective hoisted by analysts at BMO Capital Markets from $15.00 to $16.00 in a research note issued on Thursday. The firm currently has a “market perform” rating on the stock. BMO Capital Markets’ price target points to a potential upside of 0.88% from the company’s current price.

PRMW has been the subject of a number of other research reports. ValuEngine upgraded shares of Primo Water from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. BidaskClub lowered shares of Primo Water from a “hold” rating to a “sell” rating in a research note on Tuesday, March 13th. Barrington Research restated a “buy” rating and set a $20.00 price target on shares of Primo Water in a research note on Friday, April 6th. B. Riley set a $18.00 price target on shares of Primo Water and gave the company a “buy” rating in a research note on Monday, March 5th. Finally, William Blair began coverage on shares of Primo Water in a research note on Thursday. They set an “outperform” rating for the company. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $17.50.

Top 10 Medical Stocks To Own Right Now: THL Credit Senior Loan Fund(TSLF)

THL Credit Senior Loan Fund is a non-diversified, closed-end management investment company (Fund). The Fund’s investment objective is to provide current income and preservation of capital primarily through investments in United States dollar-denominated senior secured corporate loans and notes. Under normal market conditions, the Fund will invest 100% of its Managed Assets in the securities of issuers located in North America and does not currently intend to invest a material amount of its Managed Assets outside the United States. It invests in sectors, such as Business, Services, Healthcare and Pharmaceuticals, Retail, Software, Advertising, Printing and Publishing, and Diversified and Services, among others. Four Wood Capital Advisors LLC serves as the Fund’s investment adviser. Advisors’ Opinion:

Top 10 Medical Stocks To Own Right Now: Catalyst Biosciences, Inc. (CBIO)

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. Its product pipeline includes CB 813d, a Factor VIIa drug candidate that completed a Phase I clinical trials evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity in severe hemophilia A and B patients with and without inhibitors. The company’s preclinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of patients with hemophilia B; and a Factor Xa variant. It is also developing CB 2782, an anti-C3 inflammation development candidate for the treatment of delayed graft function in kidney transplants; and an ophthalmic anti-C3 candidate for treatment of dry age-related macular degeneration. The company has collaboration agreement with Pfizer, Inc. for the development of human Factor VIIa products; and ISU Abxis for development and manufacturing of the Factor IX products through Phase I/II clinical trials. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Catalyst Biosciences (CBIO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Catalyst Biosciences Inc. (NASDAQ: CBIO) is scheduled to present interim data from its Phase 2 study of Marzeptacog alfa (MarzAA) on July 18. This data will be pertaining to the subcutaneous efficacy trial in individuals with hemophilia A or B with inhibitors to evaluate the ability of MarzAA to minimize spontaneous bleeding episodes.

  • [By Joseph Griffin]

    B. Riley lowered shares of Catalyst Biosciences (NASDAQ:CBIO) from a buy rating to a neutral rating in a research report released on Thursday, MarketBeat reports. They currently have $12.50 price objective on the biopharmaceutical company’s stock, down from their prior price objective of $44.00.

  • [By Cory Renauer]

    If you’re looking for biotech stock bargains, the scrap heap isn’t a bad place to start. Hardly a day goes by without a biotech meltdown somewhere, and clinical trial mishaps led to market clubbings for Anika Therapeutics (NASDAQ:ANIK) and Catalyst Biosciences (NASDAQ:CBIO) earlier this week.

Top 10 Medical Stocks To Own Right Now: RELX PLC(RELX)

RELX Group is a global provider of information and analytics for professional and business customers across industries.
Our goal is to help customers make better decisions, get better results and be more productive. We do this by leveraging a deep understanding of our customers to create innovative solutions which combine content and data with analytics and technology in global platforms.
The Group has customers in more than 180 countries and has offices in about 40 countries. The Group employs approximately 30,000 staff.
We operate in four major market segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions.

? Scientific, Technical & Medical helps customers advance science and improve healthcare by providing information and analytical solutions that enable them to make critical decisions, enhance productivity, and improve outcomes.   Advisors’ Opinion:

  • [By Joseph Griffin]

    First Republic Investment Management Inc. acquired a new position in shares of Relx PLC (NYSE:RELX) in the 2nd quarter, Holdings Channel reports. The fund acquired 13,205 shares of the technology company’s stock, valued at approximately $287,000.

  • [By Joseph Griffin]

    Relx PLC (NYSE:RELX)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $20.27 and last traded at $20.29, with a volume of 6975 shares traded. The stock had previously closed at $20.35.

  • [By Joseph Griffin]

    Relx (NYSE: RELX) and Cambium Learning Group (NASDAQ:ABCD) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Top 10 Medical Stocks To Own Right Now: Cherry Hill Mortgage Investment Corporation(CHMI)

Cherry Hill Mortgage Investment Corporation, incorporated on October 31, 2012, is a residential real estate finance company. The Company is focused on acquiring, investing in and managing residential mortgage assets in the United States. Its principal objective is to generate attractive current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The Company focuses on attaining this objective, subject to market conditions and availability and terms of financing, by selectively constructing and managing a targeted portfolio of Servicing Related Assets, residential mortgage-backed securities (RMBS), prime mortgage loans and other cashflowing residential mortgage assets. The Company operates its business through segments, including investments in RMBS; investments in Servicing Related Assets, and All Other. The Company’s targeted asset classes include servicing related assets consisting of mortgage servicing rights (MSRs) and Excess MSRs; RMBS, including Agency RMBS, residential mortgage pass-through certificates, collateralized mortgage obligations (CMOs) (interest-only security (IO) and inverse IOs) and to-be-announced (TBA), and prime mortgage loans. The Company is externally managed by Cherry Hill Mortgage Management, LLC.

The Company also may generate MSRs through the purchase of prime mortgage loans. Its RMBS strategy focuses primarily on the acquisition and ownership of Agency RMBS that are whole-pool, residential mortgage pass-through certificates. However, from time to time, the Company invests in CMOs, including IOs and inverse IOs. Its RMBS strategy includes selective investments in non-Agency RMBS, including government-sponsored enterprise (GSE) risk-sharing securities.

Advisors’ Opinion:

  • [By Max Byerly]

    Cherry Hill Mortgage Investment (NYSE:CHMI) and Great Portland Estates (OTCMKTS:GPEAF) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.

  • [By Ethan Ryder]

    Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Cherry Hill Mortgage Investment Corp (NYSE:CHMI) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 152,335 shares of the real estate investment trust’s stock, valued at approximately $2,721,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.98% of Cherry Hill Mortgage Investment as of its most recent filing with the SEC.

Top 10 Medical Stocks To Own Right Now: Briggs & Stratton Corporation(BGG)

Briggs & Stratton Corporation designs, manufactures, markets, sells, and services air cooled gasoline engines for outdoor power equipment. It operates in two segments, Engines and Products. The Engines segment offers four-cycle aluminum alloy gasoline engines that are used primarily by the lawn and garden equipment industry. Its products are used in various lawn and garden equipment applications, including walk-behind lawn mowers, riding lawn mowers, garden tillers, and snow throwers, as well as products for industrial, construction, agricultural, and other consumer applications that include portable and standby generators, pumps, and pressure washers. This segment also manufactures and sells replacement engines and service parts to sales and service distributors. The Products segment offers portable and standby generators, pressure washers, snow throwers, lawn and garden powered equipment, turf care, and job site products. This segment sells its products through various channels of retail distribution, including consumer home centers, warehouse clubs, mass merchants, and independent dealers under its brands, including Briggs & Stratton, Simplicity, Snapper, Snapper Pro, Ferris, PowerBoss, Allmand, Billy Goat, Murray, Branco, and Victa, as well as other brands, such as Craftsman, GE, and Troy-Bilt. The company serves original equipment manufacturers worldwide. Briggs & Stratton Corporation was founded in 1908 and is headquartered in Wauwatosa, Wisconsin.

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Briggs & Stratton (BGG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jon C. Ogg]

    Generac Holdings Inc. (NYSE: GNRC) was up less than 1% at $59.20 late on Tuesday, but that is actually up by over 6% from last Friday’s close for the generator maker before the storm threat was so imminent. Briggs & Stratton Corp. (NYSE: BGG) is also in that field and its gain of just 0.3% to $20.45 late on Tuesday was actually up only about 1% from last Friday as the company is more diversified

  • [By Motley Fool Transcriber]

    Briggs & Stratton Corporation (NYSE: BGG)Q4 2018 Briggs & Stratton Corp Earnings CallAug. 16, 2018, 2 p.m. EDT

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Medical Stocks To Own Right Now: EP Energy Corporation(EPE)

EP Energy Corporation (EP Energy), incorporated on August 8, 2013, is an independent exploration and production company. The Company is engaged in the acquisition and development of unconventional onshore oil and natural gas properties in the United States. The Company operates through a diverse base of producing assets and are focused on creating value through the development of its drilling inventory located in four areas: the Eagle Ford Shale (South Texas), the Wolfcamp Shale (Permian Basin in West Texas), the Altamont Field in the Uinta Basin (Northeastern Utah) and the Haynesville Shale (North Louisiana). In its operating areas, it has identified approximately 5,710 drilling locations (including over 860 drilling locations to which it has attributed proved undeveloped reserves).

The Company has proved reserves of approximately 546.0 million barrels of oil equivalent (MMBoe) and it has an average net daily production of over 109,680 barrel of oil equivalent per day (Boe/d). Approximately 240 MMBoe of its total proved reserves are proved developed producing assets, which generates an average production of over 109.7 million barrels of oil equivalent per day (MBoe/d) from approximately 1,600 wells. The Company has approximately 300 MMBbls of proved oil reserves, over 90 MMBbls of proved natural gas liquids (NGLs) reserves and approximately 940 billion cubic feet (Bcf) of proved natural gas reserves.

Eagle Ford Shale

The Eagle Ford Shale, located in South Texas, is an unconventional oil plays in the United States. The Eagle Ford formation in La Salle county has approximately 120 feet of net thickness (over 160 feet gross). The Company has approximately 94,150 net (over 88,890 gross) acres in the Eagle Ford, in which it has identified over 970 drilling locations. The Company has approximately 570 net producing wells (over 560 net operated wells) and running one rig in this program. EP Energy’s average net daily production is approximately 58,190 Boe/d.

!

Wolfcamp Shale

The Wolfcamp Shale is located in the Permian Basin. The Wolfcamp A, B and C zones combine for over 750 feet of net (approximately 1,000 feet of gross) thickness. The Company has approximately 178,110 net (over 178,280 gross) acres in the Wolfcamp, in which it has identified approximately 3,260 drilling locations in the Wolfcamp A, B and C zones. EP Energy has approximately 240 net operated producing wells. Its average net daily production is over 19,850 Boe/d.

Altamont

The Altamont field is located in the Uinta Basin in northeastern Utah. The Company’s operations are focused on developing the Altamont Field Complex (consisting of the Altamont, Bluebell and Cedar Rim fields). It owns approximately 180,940 net (over 323,210 gross) acres in Duchesne and Uinta Counties. The Altamont Field Complex has a gross pay interval thickness of over 4,300 feet. Its commingled production is from over 1,500 feet of net stimulated rock. The Company’s activity is focused on the development of its vertical inventory on approximately 80-acre and 160-acre spacing. The Company has identified approximately 1,280 drilling locations. EP Energy has approximately 390 net producing wells (over 380 net operated wells). The Company’s average net daily production is approximately 17,140 Boe/d.

Haynesville Shale

The Company holds natural gas assets in the Haynesville Shale, located in East Texas and Northern Louisiana. The Company’s operations are concentrated primarily in Desoto Parish, Louisiana in the Holly Field. It has approximately 34,170 net (over 52,930 gross) acres in this area. EP Energy has identified over 190 drilling locations. The Company’s average net daily production is approximately 90 million cubic feet per day (MMcf/d).

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    EP Energy Corp  (NYSE:EPE)Q4 2018 Earnings Conference CallMarch 15, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Enterprise GP (EPE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Enterprise GP Holdings L.P. (NYSE:EPE) shares were up 5.5% during trading on Wednesday . The stock traded as high as $2.55 and last traded at $2.51. Approximately 939,243 shares traded hands during mid-day trading, a decline of 13% from the average daily volume of 1,077,065 shares. The stock had previously closed at $2.38.

Top 10 Medical Stocks To Own Right Now: MuniVest Fund, Inc.(MVF)

BlackRock MuniVest Fund, Inc. (the Fund), formerly known as MuniVest Fund, Inc., is a non-diversified, closed-end management investment company. The Fund seeks to provide a high a level of current income exempt from federal income taxes by investing primarily in a portfolio of long-term, investment-grade municipal obligations, the interest on which is exempt from federal income taxes.

BlackRock MuniVest Fund, Inc. may invest in certain securities, whose income return is inversely related to changes in a floating interest rate (inverse floaters). The Fund may invest in swap agreements. The Fund may also purchase and write call and put options. BlackRock MuniVest Fund, Inc.’s investment advisor is BlackRock Advisors, LLC, a wholly owned subsidiary of BlackRock, Inc. The Fund’s sub-advisor is BlackRock Investment Management, LLC.

Advisors’ Opinion:

  • [By Max Byerly]

    BlackRock MuniVest Fund Inc. (NYSEAMERICAN:MVF) declared a monthly dividend on Thursday, September 6th, Wall Street Journal reports. Stockholders of record on Friday, September 14th will be paid a dividend of 0.041 per share by the investment management company on Monday, October 1st. This represents a $0.49 annualized dividend and a dividend yield of 5.57%. The ex-dividend date of this dividend is Thursday, September 13th.

Top 10 Medical Stocks To Own Right Now: Basilea Pharmaceutica Ltd. (BPMUF)

Basilea Pharmaceutica AG is a Switzerland-based company engaged in the research, development and commercialization of pharmaceutical products. The Company focuses on pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology. The Company has a range of drugs to treat drug-resistant bacterial infections, systemic fungal infections and drug-resistant tumors. The Company’s anti-infectives, including isavuconazole and ceftobiprole are in late-stage clinical development, while the novel antibiotic, BAL30072 and the oncology compound, BAL101553 are in clinical phase I. The Company’s subsidiaries include Basilea Pharmaceutica China Ltd., Basilea Pharmaceuticals A/S, Basilea Pharma SAS, Basilea Pharmaceutica Deutschland GmbH, Basilea Pharmaceutica International Ltd., BPh Investitionen Ltd., Basilea Medical Ltd. and Basilea Pharmaceuticals Ltd. Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Basilea Pharmaceutica (BPMUF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Basilea Pharmaceuticals (OTC:BPMUF)

    BPMUF Is a Swiss company with commercialized products in the anti-infection space, but they are also working on agents in cancer research. One of these agents, BAL101553, is a prodrug of a so-called “tumor checkpoint controller” inhibitor, which destabilizes microtubules to disrupt dividing cells. This phase 1/2a study assessed the safety and the recommended dosage for this agent. The phase 1 portion of the trial recruited 20 patients to receive various doses of BAL101553.

Top 10 Medical Stocks To Own Right Now: SunCoke Energy Partners, L.P.(SXCP)

SunCoke Energy Partners, L.P., (the “Partnership,” “we,” “our” and “us”), is a Delaware limited partnership formed in July 2012, which primarily produces coke used in the blast furnace production of steel. We also provide coal handling and/or mixing services at our Coal Logistics terminals. At December 31, 2015, we owned a 98.0 percent interest in Haverhill Coke Company LLC (“Haverhill”), Middletown Coke Company, LLC (“Middletown”) and Gateway Energy and Coke Company, LLC (“Granite City”). At December 31, 2015, SunCoke Energy, Inc. (“SunCoke”) owned the remaining 2.0 percent interest in each of Haverhill, Middletown, and Granite City, and, through its subsidiary, owned a 53.9 percent partnership interest in us and all of our incentive distribution rights and indirectly owns and controls our general partner, which holds a 2.0 percent general partner interest in us. Coke is a principal raw material in the blast furnace steelmaking process.   Advisors’ Opinion:

  • [By Stephan Byrd]

    Bramshill Investments LLC cut its stake in SunCoke Energy Partners LP (NYSE:SXCP) by 4.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 113,454 shares of the energy company’s stock after selling 4,786 shares during the period. Bramshill Investments LLC’s holdings in SunCoke Energy Partners were worth $1,702,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    SunCoke Energy Partners (NYSE:SXCP) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    Teligent (NASDAQ:TLGT) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Stephan Byrd]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get SunCoke Energy Partners alerts:

    SunCoke Energy Partners LP Declares Quarterly Dividend of $0.40 (SXCP) (americanbankingnews.com) SunCoke Energy Partners (SXCP) Scheduled to Post Earnings on Wednesday (americanbankingnews.com) SunCoke Energy Partners LP (SXCP) Receives Consensus Rating of “Hold” from Brokerages (americanbankingnews.com) Head to Head Survey: SunCoke Energy Partners (SXCP) vs. APERAM/SH N Y REGISTRY SH (APEMY) (americanbankingnews.com)

    Shares of SunCoke Energy Partners traded down $0.05, hitting $15.85, during trading on Friday, MarketBeat reports. 105,181 shares of the company were exchanged, compared to its average volume of 66,406. The firm has a market capitalization of $735.01 million, a price-to-earnings ratio of 9.61 and a beta of 1.44. SunCoke Energy Partners has a fifty-two week low of $14.70 and a fifty-two week high of $21.95. The company has a quick ratio of 0.83, a current ratio of 1.54 and a debt-to-equity ratio of 1.34.

  • [By Shane Hupp]

    SunCoke Energy Partners (NYSE: SXCP) and AK Steel (NYSE:AKS) are both small-cap oils/energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Top 10 Medical Stocks To Own Right Now: TG Therapeutics, Inc.(TGTX)

TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. It develops TG-1101 (ublituximab), a novel glycol engineered monoclonal antibody that targets a epitope on the CD20 antigen found on the surface of B-lymphocytes developed to aid in the depletion of circulating B-cells; and TG-1101 in combination with TGR-1202 for relapsed/refractory non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. The company also develops TGR-1202, an orally available phosphoinositide-3-kinase delta inhibitor with nanomolar potency to the delta isoform and high selectivity over the alpha, beta, and gamma isoforms, as well as for hematologic malignancies. In addition, it develops a pre-clinical program to develop the inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4); and anti-PD-L1 and anti-GITR antibody research programs that are in pre-clinical development stage in the field of hematological malignancies. The company has license agreements with LFB Biotechnologies S.A.S, GTC Biotherapeutics, LFB/GTC LLC, and Ildong Pharmaceutical Co. Ltd. for the development and commercialization of TG-1101; Rhizen Pharmaceuticals, SA for the development and commercialization of TGR-1202; and Ligand Pharmaceuticals Incorporated for the development and commercialization of IRAK4 inhibitor technology. It also has a collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Todd Campbell]

    Fueled by trial data, TG Therapeutics (NASDAQ:TGTX) shares skyrocketed 69.5% in February, according to S&P Global Market Intelligence.

    So what

    On Jan. 30, data from phase 1 trials evaluating TG Therapeutics’ ublituximab and umbralisib alongside J&J and AbbVie’s Imbruvica was published in Lancet, a respected industry journal. 

  • [By Logan Wallace]

    Shares of TG Therapeutics Inc (NASDAQ:TGTX) have received a consensus rating of “Buy” from the eight research firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $12.30.

  • [By George Budwell]

    Shares of the B-cell malignancy and autoimmune disease specialist TG Therapeutics (NASDAQ:TGTX) fell by an eye-popping 55.9% last month, according to data from S&P Global Market Intelligence. What triggered this dramatic sell-off?

Top 5 Undervalued Stocks To Invest In 2019

Our Long Idea reports aim to identify those firms that the market has overlooked and that, when analyzed beyond standard metrics, are significantly undervalued. These hidden gems provide excellent upside potential to any portfolio, with little downside risk.

In addition to individual Long Ideas, we provide Model Portfolios that provide well-screened lists of companies based on specific criteria such as return on invested capital (ROIC) or dividend yield. In 2016, we added two new Model Portfolios, Exec Comp Aligned With ROIC and Safest Dividend Yields, to go along with our longstanding Most Attractive & Most Dangerous Stocks Model Portfolio, which has a long history of outperformance.

Below presents the Long Idea highlights of 2016 and the performance of our new Model Portfolios.

Long Idea Highlights

It pays to read our Long Idea reports. In 2016, 10 out of our 15 Long Idea stock and mutual fund picks saw positive returns and 13 stocks outperformed the market (S&P 500). All told, the Long Idea stocks averaged a 9.9% return in 2016, which was slightly more than the S&P 500’s return of nearly 9.5%, thereby outperforming as a long portfolio. Some of the top picks can be seen in Figure 1 below.

Top 5 Undervalued Stocks To Invest In 2019: Old Second Bancorp Inc.(OSBC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Old Second Bancorp (OSBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Old Second Bancorp (OSBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Undervalued Stocks To Invest In 2019: Adaptimmune Therapeutics plc(ADAP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Adaptimmune Therapeutics (NASDAQ:ADAP) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.24) by $0.20, Bloomberg Earnings reports. Adaptimmune Therapeutics had a negative return on equity of 32.26% and a negative net margin of 185.39%. During the same quarter in the prior year, the business earned ($3.00) EPS.

  • [By ]

    Cramer was bearish on Chesapeake Energy (CHK) , Adaptimmune Therapeutics (ADAP) , Icahn Enterprises (IEP) , Bristol-Myers Squibb (BMY) , Quad/Graphics (QUAD) , Spectra Energy Partners (SEP) and L Brands (LB) .

  • [By Logan Wallace]

    Here are some of the news stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Adaptimmune Therapeutics alerts:

    Analysts Anticipate Adaptimmune Therapeutics PLC – (ADAP) to Post -$0.28 Earnings Per Share (americanbankingnews.com) Peritoneal Cancer Market Pipeline Review H1- Target Drug Profile, Top Industry Intelligence, Major Key Players and … (thefreenewsman.com) Escherichia coli Infections Market Research Report Pipeline Review H1 Assessment by Mechanism of Action, Drug … (theperfectinvestor.com) Adaptimmune Therapeutics plc (ADAP): Do You Have This Stock in Portfolio?: (bitcoinpriceupdate.review)

    Several equities analysts have weighed in on the company. Leerink Swann reissued an “outperform” rating on shares of Adaptimmune Therapeutics in a report on Thursday, March 15th. BidaskClub downgraded Adaptimmune Therapeutics from a “hold” rating to a “sell” rating in a research report on Wednesday. ValuEngine upgraded Adaptimmune Therapeutics from a “buy” rating to a “strong-buy” rating in a research report on Monday. SunTrust Banks increased their target price on Adaptimmune Therapeutics to $18.00 and gave the stock a “buy” rating in a research report on Thursday, May 10th. Finally, Cowen restated a “buy” rating on shares of Adaptimmune Therapeutics in a research report on Wednesday, May 9th. Two equities research analysts have rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $16.94.

  • [By ]

    Adaptimmune Therapeutics (ADAP) : “If you’ve speculated on this one, you’ve won. Let’s move on.”

    Icahn Enterprises (IEP) : “I don’t really know what they own so I can’t recommend it.”

Top 5 Undervalued Stocks To Invest In 2019: Lumber Liquidators Holdings, Inc(LL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Lumber Liquidators Holdings Inc (NYSE:LL) has received an average rating of “Hold” from the fourteen brokerages that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $27.11.

  • [By Logan Wallace]

    News headlines about Lumber Liquidators (NYSE:LL) have trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Lumber Liquidators earned a coverage optimism score of 0.02 on Accern’s scale. Accern also assigned headlines about the specialty retailer an impact score of 46.3646121092683 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Neha Chamaria]

    Lumber Liquidators (NYSE:LL) shares fell through the floor in the first quarter of the year, losing more than one-third in value; they regained some ground to end the first half of 2018 down 22.4%, according to data provided by S&P Global Market Intelligence. Going by the stock’s recovery in the past couple of months — July has also been strong so far — it seems investors are betting on better days ahead for the flooring retailer.

  • [By Rick Munarriz]

    Lumber Liquidators (NYSE:LL), Camping World Holdings (NYSE:CWH), and Sohu.com (NASDAQ:SOHU) have taken a beating this year. They’re among the biggest losers through the first three quarters of 2018. Let’s go over why I think they have a shot at bouncing back in the next three months.

  • [By Jason Hall]

    It may not feel as if it can get much worse for Lumber Liquidators Holdings Inc. (NYSE:LL) shareholders. The flooring retailer reported second-quarter results on July 31, and Mr. Market added more injury to an already painful year, sending shares down more than 20% by the time the market closed. And while the company continues to face challenges, including relatively weak traffic growth and high expenses, it probably had a better second quarter than the market’s reaction would indicate. 

Top 5 Undervalued Stocks To Invest In 2019: Buenaventura Mining Company Inc.(BVN)

Advisors’ Opinion:

  • [By Logan Wallace]

    ClariVest Asset Management LLC raised its position in shares of Compania de Minas Buenaventura SAA (NYSE:BVN) by 22.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 347,900 shares of the mining company’s stock after purchasing an additional 64,500 shares during the period. ClariVest Asset Management LLC owned approximately 0.14% of Compania de Minas Buenaventura SAA worth $4,742,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Employees Retirement System of Texas bought a new position in shares of Compania de Minas Buenaventura SAA (NYSE:BVN) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 231,000 shares of the mining company’s stock, valued at approximately $3,149,000.

  • [By Shane Hupp]

    Compania de Minas Buenaventura SAA (NYSE:BVN) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued to investors on Monday.

Top 5 Undervalued Stocks To Invest In 2019: RELX PLC(RELX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Relx (NYSE: RELX) and Cambium Learning Group (NASDAQ:ABCD) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

  • [By Joseph Griffin]

    Relx PLC (NYSE:RELX)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $20.27 and last traded at $20.29, with a volume of 6975 shares traded. The stock had previously closed at $20.35.

  • [By Max Byerly]

    Oppenheimer Asset Management Inc. decreased its position in RELX Group (NYSE:RELX) by 33.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 26,655 shares of the technology company’s stock after selling 13,198 shares during the period. Oppenheimer Asset Management Inc.’s holdings in RELX Group were worth $557,000 at the end of the most recent quarter.

Top 10 Heal Care Stocks To Invest In Right Now

Catchmark Timber Trust Inc (NYSE:CTT) shares reached a new 52-week low during trading on Tuesday . The stock traded as low as $11.07 and last traded at $11.17, with a volume of 5862 shares trading hands. The stock had previously closed at $11.27.

Several research analysts recently commented on the company. Zacks Investment Research raised Catchmark Timber Trust from a “sell” rating to a “hold” rating in a research note on Tuesday, June 5th. ValuEngine raised Catchmark Timber Trust from a “hold” rating to a “buy” rating in a research note on Tuesday, June 26th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Catchmark Timber Trust presently has a consensus rating of “Buy” and an average price target of $14.13.

Top 10 Heal Care Stocks To Invest In Right Now: Carrizo Oil & Gas, Inc.(CRZO)

Advisors’ Opinion:

  • [By Max Byerly]

    BidaskClub upgraded shares of Carrizo Oil & Gas (NASDAQ:CRZO) from a hold rating to a buy rating in a report published on Wednesday morning.

    Several other research firms have also commented on CRZO. Royal Bank of Canada reissued a buy rating and set a $29.00 price target on shares of Carrizo Oil & Gas in a research report on Thursday, July 12th. Zacks Investment Research lowered shares of Carrizo Oil & Gas from a buy rating to a hold rating in a research report on Thursday, July 26th. Stifel Nicolaus cut their price objective on shares of Carrizo Oil & Gas from $44.00 to $34.00 and set a buy rating on the stock in a report on Thursday, June 28th. Jefferies Financial Group restated a hold rating and set a $27.00 price objective on shares of Carrizo Oil & Gas in a report on Wednesday, July 18th. Finally, Williams Capital restated a buy rating and set a $41.00 price objective on shares of Carrizo Oil & Gas in a report on Monday, July 23rd. Nine equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of Buy and a consensus target price of $29.58.

  • [By Benzinga News Desk]

    Carl Icahn fired off a letter to the board of AmTrust Financial Services (NASDAQ: AFSI) Thursday, blasting the firm for pursuing an “opportunistic going-private transaction” that would squeeze out minority shareholders: Link

    ECONOMIC DATA
    Federal Reserve Bank of Dallas President Robert Kaplan will speak at 9:15 a.m. ET.
    Federal Reserve Governor Lael Brainard is set to speak at 9:15 a.m. ET.
    The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.
    ANALYST RATINGS
    Evercore upgraded Marriott (NASDAQ: MAR) from In-Line to Outperform
    Piper Jaffray upgraded Mellanox Technologies (NASDAQ: MLNX) from Neutral to Overweight
    Jefferies downgraded Carrizo Oil (NASDAQ: CRZO) from Buy to Hold
    Imperial downgraded Planet Fitness (NYSE: PLNT) from Outperform to In-Line

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Carrizo Oil & Gas (CRZO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Carmignac Gestion raised its position in shares of Carrizo Oil & Gas Inc (NASDAQ:CRZO) by 122.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,000,000 shares of the oil and gas producer’s stock after purchasing an additional 550,000 shares during the quarter. Carmignac Gestion owned 1.22% of Carrizo Oil & Gas worth $16,000,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Carrizo Oil & Gas (NASDAQ:CRZO) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Tuesday.

Top 10 Heal Care Stocks To Invest In Right Now: RELX PLC(RELX)

Advisors’ Opinion:

  • [By Max Byerly]

    Oppenheimer Asset Management Inc. decreased its position in RELX Group (NYSE:RELX) by 33.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 26,655 shares of the technology company’s stock after selling 13,198 shares during the period. Oppenheimer Asset Management Inc.’s holdings in RELX Group were worth $557,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Relx (NYSE: RELX) and Cambium Learning Group (NASDAQ:ABCD) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

  • [By Joseph Griffin]

    Relx PLC (NYSE:RELX)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $20.27 and last traded at $20.29, with a volume of 6975 shares traded. The stock had previously closed at $20.35.

  • [By Joseph Griffin]

    First Republic Investment Management Inc. acquired a new position in shares of Relx PLC (NYSE:RELX) in the 2nd quarter, Holdings Channel reports. The fund acquired 13,205 shares of the technology company’s stock, valued at approximately $287,000.

Top 10 Heal Care Stocks To Invest In Right Now: Patriot National, Inc.(PN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media stories about Patriot National (NYSE:PN) have trended somewhat negative on Thursday, Accern reports. The research group identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Patriot National earned a media sentiment score of -0.01 on Accern’s scale. Accern also gave news articles about the financial services provider an impact score of 42.7409526634833 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Top 10 Heal Care Stocks To Invest In Right Now: Olympic Steel Inc.(ZEUS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Headlines about Olympic Steel (NASDAQ:ZEUS) have been trending somewhat positive on Tuesday, Accern reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Olympic Steel earned a news sentiment score of 0.13 on Accern’s scale. Accern also gave news coverage about the basic materials company an impact score of 47.5465348320487 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Olympic Steel (ZEUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Olympic Steel (NASDAQ:ZEUS) was downgraded by investment analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Friday.

Top 10 Heal Care Stocks To Invest In Right Now: MYR Group Inc.(MYRG)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00.
    Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday.
    STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results.
    Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday.
    Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share.
    YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15.
    MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings.
    TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results.
    Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings.
    TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results.
    Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings.
    Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results.
    Logitech International S.A. (NASDAQ: LOGI)
  • [By Joseph Griffin]

    Strs Ohio raised its position in MYR Group Inc (NASDAQ:MYRG) by 95.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 10,900 shares of the utilities provider’s stock after buying an additional 5,326 shares during the quarter. Strs Ohio’s holdings in MYR Group were worth $307,000 as of its most recent filing with the SEC.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Ethan Ryder]

    MYR Group, Inc. (NASDAQ:MYRG) Director William A. Koertner sold 11,768 shares of the firm’s stock in a transaction dated Wednesday, May 16th. The shares were sold at an average price of $39.15, for a total transaction of $460,717.20. Following the transaction, the director now directly owns 315,012 shares in the company, valued at $12,332,719.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Top 10 Heal Care Stocks To Invest In Right Now: Dril-Quip, Inc.(DRQ)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Dril-Quip (DRQ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    TRADEMARK VIOLATION WARNING: “Louisiana State Employees Retirement System Has $285,000 Position in Dril-Quip, Inc. (DRQ)” was published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another publication, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this report can be read at www.tickerreport.com/banking-finance/4129407/louisiana-state-employees-retirement-system-has-285000-position-in-dril-quip-inc-drq.html.

  • [By Jon C. Ogg]

    Dril-Quip Inc. (NYSE: DRQ) was started with an Underweight rating and assigned a target price of $50 (versus a $49.80 close, after a 1.5% gain). The shares were last seen down five cents at $49.75, in a 52-week range of $37.35 and with a consensus target price of $45.13.

Top 10 Heal Care Stocks To Invest In Right Now: MDC Partners Inc.(MDCA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of MDC Partners Inc. (NASDAQ: MDCA) were down 37 percent to $4.32 after a first-quarter earnings miss.

    Hudson Technologies Inc. (NASDAQ: HDSN) was down, falling around 29 percent to $2.9199 after the company reported downbeat Q1 earnings.

  • [By Lisa Levin]

    Shares of MDC Partners Inc. (NASDAQ: MDCA) were down 33 percent to $ 4.575 after a first-quarter earnings miss.

    Hudson Technologies Inc. (NASDAQ: HDSN) was down, falling around 32 percent to $2.7799 after the company reported downbeat Q1 earnings.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on MDC Partners (MDCA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

Top 10 Heal Care Stocks To Invest In Right Now: Repligen Corporation(RGEN)

Advisors’ Opinion:

  • [By Max Byerly]

    Meadow Creek Investment Management LLC increased its position in shares of Repligen Co. (NASDAQ:RGEN) by 21.7% in the second quarter, HoldingsChannel reports. The firm owned 7,840 shares of the biotechnology company’s stock after acquiring an additional 1,400 shares during the quarter. Meadow Creek Investment Management LLC’s holdings in Repligen were worth $369,000 as of its most recent SEC filing.

  • [By Motley Fool Transcribers]

    Repligen Corp  (NASDAQ:RGEN)Q4 2018 Earnings Conference CallFeb. 21, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    CytRx (NASDAQ: RGEN) and Repligen (NASDAQ:RGEN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations.

  • [By Joseph Griffin]

    Repligen (NASDAQ:RGEN) updated its FY18 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.69-0.73 for the period, compared to the Thomson Reuters consensus estimate of $0.70. The company issued revenue guidance of $182-188 million, compared to the consensus revenue estimate of $183.48 million.

  • [By Maxx Chatsko]

    That said, there may not be a better way to build wealth. It’s the tactic Warren Buffett relied on to become a billionaire. In fact, he didn’t reach the milestone until he turned 56 years old. Investors looking for great companies they can buy and hold for the next decade (or longer) should take a closer look at consumer water technology specialist A.O. Smith (NYSE:AOS), lithium producer Albemarle (NYSE:ALB), and biopharma enabler Repligen (NASDAQ:RGEN).

Top 10 Heal Care Stocks To Invest In Right Now: Patterson-UTI Energy, Inc.(PTEN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Patterson-UTI Energy (PTEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    First Pacific Advisors LLC decreased its holdings in Patterson-UTI Energy, Inc. (NASDAQ:PTEN) by 15.9% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,451,909 shares of the oil and gas company’s stock after selling 273,567 shares during the quarter. First Pacific Advisors LLC owned 0.65% of Patterson-UTI Energy worth $25,423,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Patterson-UTI Energy (PTEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Invest In Right Now: Tahoe Resources, Inc.(TAHO)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Nonetheless, there are many smaller players with slick investor presentations making promises of big rewards. That could sound intriguing if you’ve caught the gold bug, but it’s important to remember the risks involved when investing in the industry. Luckily, some gold stocks come with big red flags and flashing red lights. Here’s why investors might want to avoid Hecla Mining (NYSE:HL), Tahoe Resources (NYSE:TAHO), and Randgold Resources (NASDAQ:GOLD).

  • [By Neha Chamaria]

    Shares of Tahoe Resources (NYSE:TAHO) can’t seem to find a bottom. The gold and silver mining stock tumbled 23.1% in August, according to data provided by S&P Global Market Intelligence, hitting multiyear lows.

  • [By Ethan Ryder]

    Tahoe Resources (TSE:THO) (NASDAQ:TAHO) was downgraded by analysts at Beacon Securities from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday. They currently have a C$5.75 price target on the stock, down from their prior price target of C$10.00. Beacon Securities’ price objective would indicate a potential upside of 61.52% from the company’s current price.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Tahoe Resources (TAHO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

    Get Tahoe Resources alerts:

    Eloro Resources Provides Update on La Victoria Gold Project, Peru (globenewswire.com) Tahoe Resources Inc (TAHO) Receives Consensus Rating of “Hold” from Brokerages (americanbankingnews.com) Tahoe Resources – Second-Quarter Earnings Results Analysis (seekingalpha.com) Western wildfires cast cloud on annual Lake Tahoe Summit (reviewjournal.com) Wildfires in Nevada, California cast cloud on annual Lake Tahoe Summit (reviewjournal.com)

    TAHO traded down $0.03 on Monday, reaching $4.31. 42,970 shares of the company traded hands, compared to its average volume of 2,389,382. Tahoe Resources has a one year low of $3.76 and a one year high of $7.00. The firm has a market capitalization of $1.36 billion, a price-to-earnings ratio of 16.00 and a beta of 0.11. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.97 and a quick ratio of 0.95.

  • [By Shane Hupp]

    Tahoe Resources Inc (TSE:THO) (NASDAQ:TAHO) has received a consensus rating of “Hold” from the nine brokerages that are covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is C$8.33.

Hot Undervalued Stocks For 2019

Peter Krauth

After hitting a distinct bottom early in the last week, silver prices have already bounced back impressively despite ongoing U.S. dollar strength. After starting May near $16.25, the price of silver rallied to a high near $16.47 last week.

The other challenge that silver faced was the news the market awaited from the FOMC meeting on Wednesday, May 2. After the meeting, the committee announced that it would not be hiking interest rates and said inflation continues to move higher.

After peaking on Tuesday, May 1, the gold/silver ratio has quietly begun trending downward once again. I think this is in recognition of silver’s underperformance and undervalued state relative to gold.

Hot Undervalued Stocks For 2019: RELX PLC(RELX)

Advisors’ Opinion:

  • [By Max Byerly]

    Oppenheimer Asset Management Inc. decreased its position in RELX Group (NYSE:RELX) by 33.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 26,655 shares of the technology company’s stock after selling 13,198 shares during the period. Oppenheimer Asset Management Inc.’s holdings in RELX Group were worth $557,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Relx (NYSE: RELX) and Cambium Learning Group (NASDAQ:ABCD) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Hot Undervalued Stocks For 2019: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By Keith Speights]

    Should Aurora actually buy MedReleaf, there could be considerable pressure on Canopy to make an acquisition of its own. One obvious target to buy would be Aphria (NASDAQOTH:APHQF), which has roughly the same market cap as MedReleaf. But would this acquisition make sense for Canopy Growth? I think it could.

  • [By Javier Hasse]

    Here are some of the top marijuana stocks in U.S. exchanges and how the performed over the last five trading days (percentages reflect approximate equity moves as of the time of the writing of this article.

    22nd Century Group Inc (NYSE: XXII): up 4.5 percent
    Aphria Inc (OTC: APHQF): down 1.4 percent
    Aurora Cannabis Inc (OTC: ACBFF): up 0.6 percent
    Cannabis Sativa Inc (OTC: CBDS): down 6.3 percent
    CannTrust Holdings Inc (OTC: CNTTF): down 3.3 percent
    Canopy Growth Corp (NYSE: CGC): up 1.8 percent
    Cronos Group Inc. (NASDAQ: CRON): up 9.3 percent
    GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH): up 2.2 percent
    Hiku Brands Company Ltd(OTC: DJACF): down 15.5 percent
    India Globalization Capital, Inc. (NYSE: IGC): down 1.9 percent
    iAnthus Capital Holdings Inc (OTC: ITHUF): up 4.6 percent
    MassRoots Inc (OTC: MSRT): down 0.2 percent
    MedReleaf Corp(OTC: MEDFF): up 1.1 percent
    Scotts Miracle-Gro Co (NYSE: SMG): down 3.6 percent
    THC Biomed Intl Ltd (OTC: THCBF): down 5.5 percent
    Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE): up 7.3 percent
    In Other News

    A consortium of cannabis-related media professionals are conducting a Cannabis Media Survey. You can answer following this link.

  • [By Keith Speights]

    Most Canadian marijuana stocks, including Canopy Growth (NYSE:CGC), Aurora Cannabis (NASDAQOTH:ACBFF), and Aphria (NASDAQOTH:APHQF), jumped on Wednesday after the historic vote. What’s next? There will likely be five phases Canadian marijuanastocks will experience.

  • [By SEEKINGALPHA.COM]

    Yesterday we wrote that we saw rampant red flags with Aphrias (OTCQB:APHQF) proposed Nuuvera (OTC:NUUVF) transaction. In particular, the transaction seemed to make little economic or strategic sense, and we had found it worrying that a self-described Aphria advisor named Andy DeFrancesco seemed to have business dealings with both sides of the deal.

Hot Undervalued Stocks For 2019: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Exelixis (EXEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Exelixis (NASDAQ:EXEL) EVP Jeffrey Hessekiel sold 20,000 shares of the company’s stock in a transaction dated Friday, May 4th. The stock was sold at an average price of $22.36, for a total transaction of $447,200.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

  • [By Stephan Byrd]

    Exelixis, Inc. (NASDAQ:EXEL) VP Patrick J. Haley sold 3,663 shares of the business’s stock in a transaction dated Friday, May 18th. The stock was sold at an average price of $21.61, for a total transaction of $79,157.43. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Exelixis (EXEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Orelli]

    Exelixis (NASDAQ:EXEL) and Bristol-Myers continue their love-hate relationship with results from a trial testing Exelixis’ Cabometyx and Opdivo in patients with urothelial carcinoma. The duo are already testing the combination in a phase 3 trial called CheckMate 9ER, so investors are looking for this updated data to give them confidence that the combination is continuing to work.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    With that in mind, we asked a team of Motley Fool investors to highlight a biotech stock that they think is a strong buy right now. Here’s why they picked Exelixis (NASDAQ:EXEL), Celgene (NASDAQ:CELG), and Ionis Pharmaceuticals (NASDAQ:IONS).

Hot Undervalued Stocks For 2019: Preferred Apartment Communities, Inc.(APTS)

Advisors’ Opinion:

  • [By Max Byerly]

    WINTON GROUP Ltd acquired a new stake in Preferred Apartment Communities Inc. (NYSE:APTS) during the 1st quarter, Holdings Channel reports. The firm acquired 80,485 shares of the real estate investment trust’s stock, valued at approximately $1,142,000.

  • [By Joseph Griffin]

    Preferred Apartment (NYSE:APTS) – Research analysts at B. Riley raised their FY2018 earnings estimates for shares of Preferred Apartment in a note issued to investors on Thursday, May 3rd. B. Riley analyst C. Kucera now expects that the real estate investment trust will post earnings per share of $1.45 for the year, up from their prior estimate of $1.44. B. Riley currently has a “Hold” rating and a $16.00 price target on the stock. B. Riley also issued estimates for Preferred Apartment’s Q4 2018 earnings at $0.40 EPS.

  • [By Ethan Ryder]

    Stratos Wealth Partners LTD. lifted its stake in shares of Preferred Apartment Communities Inc. (NYSE:APTS) by 135.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,089 shares of the real estate investment trust’s stock after purchasing an additional 8,113 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Preferred Apartment Communities were worth $200,000 as of its most recent SEC filing.

Hot Undervalued Stocks For 2019: Recon Technology, Ltd.(RCON)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Recon Technology (NASDAQ:RCON) has been trending positive recently, Accern Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Recon Technology earned a media sentiment score of 0.27 on Accern’s scale. Accern also assigned media headlines about the oil and gas company an impact score of 44.9374991541436 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.